19 January 2023Regulatory Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook
18 January 2023Regulatory Scandion Oncology appoints Jan Stenvang, Ph.D., Chief Scientific Officer and member of Executive Management Download Presentation Webcast Workbook
5 December 2022Regulatory Scandion Oncology announces share purchase by incoming President & CEO Download Presentation Webcast Workbook
1 December 2022Regulatory Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer Download Presentation Webcast Workbook
23 November 2022Regulatory Scandion Oncology announces share purchase by member of the Board of Directors Download Presentation Webcast Workbook
10 November 2022Regulatory Invitation to Scandion Oncology webcast and conference call November 16, 2022 Download Presentation Webcast Workbook
28 October 2022Regulatory Scandion Oncology Announces Results of Extraordinary General Meeting Download Presentation Webcast Workbook
10 October 2022Regulatory Scandion Oncology initiates part 3 of the CORIST phase II trial Download Presentation Webcast Workbook
30 September 2022Regulatory Scandion Oncology announce topline results from part 2 of the CORIST phase II trial Download Presentation Webcast Workbook
31 August 2022Regulatory Bo Rode Hansen is leaving the position as President and CEO of Scandion Oncology Download Presentation Webcast Workbook
30 August 2022Regulatory Scandion Oncology announce change to its Executive Management Download Presentation Webcast Workbook
19 August 2022Regulatory Scandion Oncology receives approvals for next parts of the CORIST trial Download Presentation Webcast Workbook